期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 13, 期 2, 页码 238-248出版社
WILEY
DOI: 10.1111/j.1582-4934.2008.00665.x
关键词
docking; virtual high-throughput screening; fragment-based drug design
资金
- Swiss Institute of Bioinformatics
- Swiss National Science Foundation [SCORE 3232B0-103172, 3200B0-103173]
- Oncosuisse [01381-08-2003]
- National Center of Competence in Research (NCCR)
- Swiss National Science Foundation
The drug discovery process has been profoundly changed recently by the adoption of computational methods helping the design of new drug candidates more rapidly and at lower costs. In silico drug design consists of a collection of tools helping to make rational decisions at the different steps of the drug discovery process, such as the identification of a biomolecular target of therapeutical interest, the selection or the design of new lead compounds and their modification to obtain better affinities, as well as pharmacokinetic and pharmacodynamic properties. Among the different tools available, a particular emphasis is placed in this review on molecular docking, virtual high-throughput screening and fragment-based ligand design.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据